Source:http://linkedlifedata.com/resource/pubmed/id/19890240
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
8 Suppl 7
|
pubmed:dateCreated |
2009-11-5
|
pubmed:abstractText |
There are currently >5 million people in the United States who have been diagnosed with Alzheimer's disease. That prevalence rate is expected to triple as the population ages. The health and economic burden due to Alzheimer's disease is a worldwide problem, with some of the greatest burden coming from the developing world as people live longer in those societies. Throughout the world, the projected growth of Alzheimer's disease is dramatic. This is a worldwide public health problem of the highest order, and there is a compelling need to develop new treatments and methods of earlier diagnosis need to slow the progression of the disease and lessen its impact.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1092-8529
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
14
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
4-7; discussion 16-8
|
pubmed:meshHeading | |
pubmed:year |
2009
|
pubmed:articleTitle |
Current and future treatments for Alzheimer's disease.
|
pubmed:affiliation |
Memory and Aging Program, Butler Hospital, Providence, USA.
|
pubmed:publicationType |
Journal Article,
Review,
Historical Article,
Research Support, Non-U.S. Gov't
|